Analysis of early death in newly diagnosed acute promyelocytic leukemia patients

af Xu, Fang, Wang, Chunli, Yin, Changxin, Jiang, Xuejie, Jiang, Ling, Wang, Zhixiang, Meng, Fanyi
Udgivet i Medicine (Baltimore) (2017)

Suppressing Hedgehog signaling reverses drug resistance of refractory acute myeloid leukemia

af Huang, Kaikai, Sun, Zhiqiang, Ding, Bingjie, Jiang, Xuejie, Wang, Zhixiang, Zhu, Yufeng, Meng, Fanyi
Udgivet i Onco Targets Ther (2019)

Clinical Comparison of Non-Myeloablative Conditioning with Anti-Thymocyte Globulin and Fludarabine for Patients with Hematologic Malignancies

af Li, Qingshan, Meng, Fanyi, Zhou, Ming, Yu, Bizhen, Mo, Wenjian, Du, Qinghua, Jiang, Xuejie, Wei, Yaming
Udgivet i Med Sci Monit (2015)

Gene mutation profile and risk stratification in AML1-ETO-positive acute myeloid leukemia based on next-generation sequencing

af Yu, Guopan, Yin, Changxin, Wu, Fuqun, Jiang, Ling, Zheng, Zhongxin, Xu, Dan, Zhou, Jiaheng, Jiang, Xuejie, Liu, Qifa, Meng, Fanyi
Udgivet i Oncol Rep (2019)

Palliative chemotherapy followed by methylation inhibitor in high-risk acute myeloid leukemia: An in vitro and clinical study

af DING, BINGJIE, WANG, ZHIXIANG, JIANG, XUEJIE, LI, XIAODONG, WANG, CHUNLI, ZHONG, QINGXIU, JIANG, LING, DAI, MIN, ZHANG, YU, WEI, QI, MENG, FANYI
Udgivet i Mol Clin Oncol (2015)

Amyloid precursor protein has clinical and prognostic significance in AML1-ETO-positive acute myeloid leukemia

af Yu, Guopan, Yin, Changxin, Jiang, Ling, Xu, Dan, Zheng, Zhongxin, Wang, Zhixiang, Wang, Chunli, Zhou, Hongsheng, Jiang, Xuejie, Liu, Qifa, Meng, Fanyi
Udgivet i Oncol Lett (2018)

The Relationship between Clinical Feature, Complex Immunophenotype, Chromosome Karyotype, and Outcome of Patients with Acute Myeloid Leukemia in China

af Ding, Bingjie, Zhou, Lanlan, Jiang, Xuejie, Li, Xiaodong, Zhong, Qingxiu, Wang, Zhixiang, Yi, Zhengshan, Zheng, Zhongxin, Yin, Changxin, Cao, Rui, Liao, Libin, Meng, Fanyi
Udgivet i Dis Markers (2015)

Gli-1/PI3K/AKT/NF-kB pathway mediates resistance to radiation and is a target for reversion of responses in refractory acute myeloid leukemia cells

af Li, Xiaodong, Chen, Fang, Zhu, Qiuhua, Ding, Bingjie, Zhong, Qingxiu, Huang, Kaikai, Jiang, Xuejie, Wang, Zhixiang, Yin, Changxin, Zhu, Yufeng, Li, Zhen, Meng, Fanyi
Udgivet i Oncotarget (2016)

Identification of Novel Molecular Markers for Prognosis Estimation of Acute Myeloid Leukemia: Over-Expression of PDCD7, FIS1 and Ang2 May Indicate Poor Prognosis in Pretreatment Pa...

af Tian, Yiming, Huang, Zoufang, Wang, Zhixiang, Yin, Changxin, Zhou, Lanlan, Zhang, Lingxiu, Huang, Kaikai, Zhou, Hongsheng, Jiang, Xuejie, Li, Jinming, Liao, Libin, Yang, Mo, Meng, Fanyi
Udgivet 2014

Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia

af Jiang, Xuejie, Jiang, Ling, Cheng, Jiaying, Chen, Fang, Ni, Jinle, Yin, Changxin, Wang, Qiang, Wang, Zhixiang, Fang, Dan, Yi, Zhengshan, Yu, Guopan, Zhong, Qingxiu, Carter, Bing Z., Meng, Fanyi
Udgivet i J Transl Med (2021)

The hypomethylating agent decitabine prior to chemotherapy improves the therapy efficacy in refractory/relapsed acute myeloid leukemia patients

af Jiang, Xuejie, Wang, Zhixiang, Ding, Bingjie, Yin, Changxin, Zhong, Qingxiu, Carter, Bing Z., Yu, Guopan, Jiang, Ling, Ye, Jieyu, Dai, Min, Zhang, Yu, Liang, Shuang, Zhao, Qingxia, Liu, Qifa, Meng, Fanyi
Udgivet i Oncotarget (2015)

Disruption of Wnt/β-catenin exerts anti-leukemia activity and synergizes with FLT3 inhibition in FLT3-mutant acute myeloid leukemia

af Jiang, Xuejie, Mak, Po Yee, Mu, Hong, Tao, Wenjing, Mak, Duncan H, Kornblau, Steven, Zhang, Qi, Ruvolo, Peter, Burks, Jared K, Zhang, Weiguo, McQueen, Teresa, Pan, Rongqing, Zhou, Hongsheng, Konopleva, Marina, Cortes, Jorge, Liu, Qifa, Andreeff, Michael, Carter, Bing Z
Udgivet i Clin Cancer Res (2018)